PMC9837082_01
Creatine kinase levels over the course of disease. Levels rose precipitously during hospital admission and normalized by discharge. (Gray shaded area corresponds to reference range: 34.0-145.0 units/L). EMG = electromyography; ER = extended release; ICU = intensive care unit.
gr1.jpg
PMC9837082_01_gr1.jpg
fig1
Acetylcarnitine levels before and after treatment. Profile prior to treatment showed a trend toward elevation of long chain acylcarnitine levels that resolved after treatment (Flow Injection Analysis, Tandem Mass Spectrometry, Mayo Clinic Laboratories).
gr2.jpg
PMC9837082_01_gr2.jpg
fig2
Repeat plasma acylcarnitine profile on treatment showed a relative shift towards short- and medium-chain acylcarnitine species (Fig. 2).